C3 Advocates Recieve Tips from Congressional Staff and Take to Capitol Hill

Posted by Catherine Knowles on March 18th, 2010

Advocates from across the country participating in C3′s 2010 Call-on Congress had the opportunity to get tips on having effective meetings with Members and Congressional staff from two staffers whose bosses are champions for the colorectal cancer community.

Theresa Vawter, Legislative Assistant for Representative Kay Granger (R-TX) who is the sponsor of the Colorectal Cancer Prevention, Early Detection, and Treatment Act (H.R. 1189) which would put in place a national colorectal cancer screening and treatment program participated in a panel along with Tom Wharton, Health Care Legislative Assistant and Speechwriter for Representative Dan Boren (D-OK).  Representative Boren is the sponsor of the Colorectal Cancer Screening and Treatment Act (H.R. 1330) which will help to increase population-based screening rates for colorectal cancer by requiring all health insurance plans, both individual and group, to cover a colonoscopy for anyone age 50 or older.

Theresa and Tom spoke with the advocates about why each of their bosses is such a champion for colorectal cancer issues.  Like too many Americans, both Representative Granger and Representative Boren have lost family members to this disease.  Each is using their position as Member of Congress to push legislation that if enacted will lower the cost of colonoscopies and expand access to screening and treatment services. Read the rest of this entry »

Colorectal Cancer Researchers, CDC Staff, and DoD Staff Address C3 Advocates During C3′s 4th Annual Call-on Congress

Posted by Catherine Knowles on March 18th, 2010

On Tuesday, March 16 C3 Advocates who attended the 4th annual conference and lobby day had the opportunity to hear from experts in colorectal cancer research and federal agencies about CRC research and cancer control efforts.

Dr. Jeffery Chou is a medical oncology fellow in the Program in Immunology at the Fred Hutchinson Cancer Research Center. Early in his research career as an undergraduate student, he studied the use of radiolabeled anti-CEA antibodies as therapy for colorectal cancer at the City of Hope which fostered in him an interest for colorectal cancer immunotherapy.  He joined the lab of Dr. Edus H. Warren at the Fred Hutchinson Cancer Research Center to study the immunobiology of colorectal cancer and develop adoptive T cell therapy against colorectal cancer. His project “Epigenetic modulation of colorectal cancer stem cells for immunotherapy” is sponsored by the 2009 AACR/C3 Colorectal Cancer Coalition fellows grant in memory of Lisa Dubow and provides pre-clinical evidence supporting the combination of the epigenetic drug decitabine and T cell therapy against the cancer-testis antigen NY-ESO-1 to treat colorectal cancer. He has also received awards from ASCO and the Cancer Research Institute to support his work.

Dr. Chou spoke to C3 Advocates about the research he has been doing into treatments for late stage colorectal cancer using funding he received from the C3: Colorectal Cancer Coalition’s Lisa Fund Grant. Read the rest of this entry »

Advocates Gather in Washington, DC for C3’s 4th Annual Conference and Lobby Day

Posted by Catherine Knowles on March 16th, 2010

Grassroots Action Committee Members (left to right) - Liz Dennis, Arlene Murphy, LaRisha Baker, Florence Kurttila, Pam Seijo, and Dave Larson helped to plan and organize the 2010 Call-on Congress

Today, colorectal cancer survivors, caregivers, physicians, and nurses brought their fight against colorectal cancer to Washington, DC.  C3 President Carlea Bauman described the importance of their voices in the war against cancer, “colorectal cancer advocates who speak up and demand change will be the ones who make a difference in the fight against this disease.”

Even with advances in screening technology colorectal cancer continues to be the second leading cancer killer of men and women combined.  In 2010, nearly 50,000 people in the United States will die from colorectal cancer.  The real tragedy is that many of these deaths could be prevented if more people took advantage of colorectal cancer screening and early detection.

Over the next two days, the advocates will hear from experts about current research and cancer control programs aiming to decrease both incidence and mortality rates from colorectal cancer. Read the rest of this entry »

Registration for the 2010 Call-on Congress Closes Feb. 1

Posted by Catherine Knowles on January 12th, 2010

March is quickly approaching, and now is the time to register for the 2010 Call-on Congress!

We already have a number of great speakers confirmed -

  • Public relations expert Caitlin Carroll will be leading a breakout session on media advocacy.
  • Dr. Jeffrey Chou will be speaking about the innovative research he has been doing with stem cells using a grant he received last year from C3′s Lisa Fund.
  • Author and CRC survivor Brenda Elsagher will be talking about her battle with cancer.
  • Donna Kimbark, PhD, PRCRP Program Manager, Congressionally Directed Medical Research Programs IPA of Battelle Memorial Institute will update attendees regarding colorectal cancer research in the Peer Reviewed Cancer Research Program and the Congressionally Directed Medical Research Programs.
  • Dr. Laura Seeff, Acting Chief, Comprehensive Cancer Control Branch, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention will be talking about the program’s recent expansion and what is in store for 2010.

Register today, to hear from these and lots of other great speakers!

Read the rest of this entry »

Tags: , Comments (1): Add a comment

Register NOW for C3′s 3rd Annual Call-on Congress!

Posted by Joe Arite on October 16th, 2008

March 22-25, 2009
Washington, DC

Imagine yourself in the Halls of Congress…fighting for an end to colorectal cancer. It can happen. You CAN do it. Read the rest of this entry »

Tags: , Comments (1): Add a comment
Page 2 of 3123